Skip to main content
logo
Zhende Medical Co., Ltd. (SHA:603301)
China flag China · Delayed Price · Currency is CNY
81.73
+0.49 (0.60%)
Sep 14, 2026, 3:00 PM CST

Zhende Medical Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
281.21260.82385.17198.4679.88595.86
Depreciation & Amortization
318.48292.65246.52242.97194.28139.3
Other Amortization
7.226.181.271.331.053.76
Loss (Gain) From Sale of Assets
8.02-0.64-93.4315.9613.530.61
Asset Writedown & Restructuring Costs
2.38-1.89.0954.328.883.31
Loss (Gain) From Sale of Investments
-32.09-10.78-7.37-12.4260.17-34.03
Provision & Write-off of Bad Debts
13.1113.1110.231.88.61.44
Other Operating Activities
91.4779.8161.66214.65116.03198.18
Change in Accounts Receivable
-204.23-112.17-255.37307.45-127.9549.71
Change in Inventory
-159.791.55-10.44-12.7-228.71279.07
Change in Accounts Payable
100.1211.63100.42-536.27507.89-426.96
Change in Other Net Operating Assets
---5.2217.3423.6
Operating Cash Flow
422.68538.49461.14452.111,246817.63
Operating Cash Flow Growth
-16.80%16.77%2.00%-63.72%52.40%-73.80%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-385.92-550.22-769.69-599.24-754.12-695.47
Sale of Property, Plant & Equipment
109.7567.53121.5912.619.586.78
Cash Acquisitions
-301.05-301.05-48.66-311.91-77.09-545.54
Divestitures
----51.57-
Investment in Securities
321.35-20.2-74.85-159.25-216.68674.44
Other Investing Activities
8.136.313.62-0.07-6.055.36
Investing Cash Flow
-247.74-797.64-767.99-1,058-992.79-554.42

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
---20.2841.55-
Long-Term Debt Issued
-1,6371,419916.91,839885
Total Debt Issued
1,0231,6371,419937.181,880885
Short-Term Debt Repaid
--15.69-28.35-16.38--
Long-Term Debt Repaid
--960.18-1,400-920.36-1,992-541.26
Lease Payments
-22.48-22.48-4.99-3.57-17.49-8.26
Total Debt Repaid
-1,191-975.87-1,428-936.74-1,992-541.26
Net Debt Issued (Repaid)
-168.98660.63-9.080.43-112.05343.74
Issuance of Common Stock
0.70.7--1,01852.5
Repurchase of Common Stock
-15.49-15.49---113.15-133.38
Common Dividends Paid
-113.71-201.49-159.4-423.72-164.25-543.65
Other Financing Activities
-68.89--0.95--172.96-98.77
Financing Cash Flow
-366.37444.34-169.43-423.28456-379.57

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-36.41-13.5421.212.81-3.7-38.29
Net Cash Flow
-227.84171.66-455.07-1,016705.55-154.65

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
36.76-11.73-308.55-147.13491.92122.16
Free Cash Flow Growth
----302.68%-93.98%
Free Cash Flow Margin
0.83%-0.27%-7.24%-3.56%8.02%2.40%
Free Cash Flow Per Share
0.14-0.04-1.16-0.552.080.54
Levered Free Cash Flow
65.4165.1-532.76-338.45226.69-336.72
Unlevered Free Cash Flow
85.0984.78-514.8-320.37247.65-321.05
Free Cash Flow After Leases
14.28-34.21-313.54-150.7474.44113.9

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
108.25165.9176.7164.5838.26475.64
Change in Working Capital
-267.11-100.86-152-264.91163.63-90.81